Annual Total Liabilities
$15.52 M
-$1.77 M-10.26%
31 December 2023
Summary:
Theriva Biologics annual total liabilities is currently $15.52 million, with the most recent change of -$1.77 million (-10.26%) on 31 December 2023. During the last 3 years, it has risen by +$12.37 million (+392.45%). TOVX annual total liabilities is now -23.34% below its all-time high of $20.25 million, reached on 01 December 2016.TOVX Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Liabilities
$15.47 M
+$729.00 K+4.94%
01 September 2024
Summary:
Theriva Biologics quarterly total liabilities is currently $15.47 million, with the most recent change of +$729.00 thousand (+4.94%) on 01 September 2024. Over the past year, it has dropped by -$2.19 million (-12.39%). TOVX quarterly total liabilities is now -48.33% below its all-time high of $29.94 million, reached on 01 September 2017.TOVX Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TOVX Total Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -10.3% | -12.4% |
| 3 y3 years | +392.4% | +212.1% |
| 5 y5 years | +170.0% | +169.2% |
TOVX Total Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -10.3% | +392.4% | -26.2% | +212.1% |
| 5 y | 5 years | -10.3% | +392.4% | -26.2% | +593.9% |
| alltime | all time | -23.3% | >+9999.0% | -48.3% |
Theriva Biologics Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $15.47 M(+4.9%) |
| June 2024 | - | $14.74 M(+0.9%) |
| Mar 2024 | - | $14.61 M(-5.9%) |
| Dec 2023 | $15.52 M(-10.3%) | $15.52 M(-12.1%) |
| Sept 2023 | - | $17.66 M(-0.2%) |
| June 2023 | - | $17.70 M(+2.3%) |
| Mar 2023 | - | $17.30 M(+0.0%) |
| Dec 2022 | $17.30 M(+248.9%) | $17.30 M(-15.8%) |
| Sept 2022 | - | $20.55 M(-0.5%) |
| June 2022 | - | $20.66 M(-1.5%) |
| Mar 2022 | - | $20.97 M(+323.1%) |
| Dec 2021 | $4.96 M(+57.3%) | - |
| Dec 2021 | - | $4.96 M(+8.7%) |
| Sept 2021 | - | $4.56 M(+29.4%) |
| June 2021 | - | $3.52 M(+58.0%) |
| Mar 2021 | - | $2.23 M(-29.3%) |
| Dec 2020 | $3.15 M(-45.2%) | $3.15 M(-3.6%) |
| Sept 2020 | - | $3.27 M(-13.1%) |
| June 2020 | - | $3.76 M(+14.7%) |
| Mar 2020 | - | $3.28 M(-42.9%) |
| Dec 2019 | $5.75 M(+55.9%) | $5.75 M(-6.9%) |
| Sept 2019 | - | $6.17 M(+39.9%) |
| June 2019 | - | $4.41 M(+21.7%) |
| Mar 2019 | - | $3.62 M(-1.7%) |
| Dec 2018 | $3.69 M(-63.8%) | $3.69 M(-13.1%) |
| Sept 2018 | - | $4.24 M(-9.2%) |
| June 2018 | - | $4.67 M(-14.5%) |
| Mar 2018 | - | $5.46 M(-46.4%) |
| Dec 2017 | $10.20 M(-49.7%) | $10.20 M(-66.0%) |
| Sept 2017 | - | $29.94 M(+134.3%) |
| June 2017 | - | $12.78 M(-24.6%) |
| Mar 2017 | - | $16.96 M(-16.3%) |
| Dec 2016 | $20.25 M(+27.8%) | $20.25 M(+42.4%) |
| Sept 2016 | - | $14.22 M(-7.6%) |
| June 2016 | - | $15.40 M(-13.3%) |
| Mar 2016 | - | $17.77 M(+12.1%) |
| Dec 2015 | $15.84 M(+65.2%) | $15.84 M(-9.5%) |
| Sept 2015 | - | $17.50 M(-31.4%) |
| June 2015 | - | $25.50 M(+66.2%) |
| Mar 2015 | - | $15.34 M(+60.0%) |
| Dec 2014 | $9.59 M(+833.6%) | $9.59 M(+874.4%) |
| Sept 2014 | - | $984.00 K(-20.1%) |
| June 2014 | - | $1.23 M(+59.4%) |
| Mar 2014 | - | $773.00 K(-24.7%) |
| Dec 2013 | $1.03 M(+160.0%) | $1.03 M(+75.9%) |
| Sept 2013 | - | $584.00 K(+155.0%) |
| June 2013 | - | $229.00 K(+16.8%) |
| Mar 2013 | - | $196.00 K(-50.4%) |
| Dec 2012 | $395.00 K(-5.3%) | $395.00 K(-5.3%) |
| Sept 2012 | - | $417.00 K(+5.6%) |
| June 2012 | - | $395.00 K(-10.8%) |
| Mar 2012 | - | $443.00 K(+6.2%) |
| Dec 2011 | $417.00 K(-21.6%) | $417.00 K(+76.4%) |
| Sept 2011 | - | $236.40 K(-40.9%) |
| June 2011 | - | $400.20 K(-66.7%) |
| Mar 2011 | - | $1.20 M(+125.6%) |
| Dec 2010 | $532.00 K | $532.00 K(+20.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2010 | - | $441.10 K(-35.7%) |
| June 2010 | - | $686.40 K(+37.0%) |
| Mar 2010 | - | $501.20 K(-5.7%) |
| Dec 2009 | $531.40 K(-14.4%) | $531.40 K(+18.3%) |
| Sept 2009 | - | $449.10 K(-21.8%) |
| June 2009 | - | $574.40 K(-26.8%) |
| Mar 2009 | - | $784.40 K(+26.4%) |
| Dec 2008 | $620.70 K(-63.2%) | $620.70 K(-8.3%) |
| Sept 2008 | - | $677.00 K(-17.1%) |
| June 2008 | - | $816.20 K(-38.0%) |
| Mar 2008 | - | $1.32 M(-21.9%) |
| Dec 2007 | $1.69 M(+131.5%) | $1.69 M(-4.1%) |
| Sept 2007 | - | $1.76 M(+7.8%) |
| June 2007 | - | $1.63 M(+42.9%) |
| Mar 2007 | - | $1.14 M(+56.6%) |
| Dec 2006 | $729.00 K(-66.0%) | $729.00 K(>+9900.0%) |
| Sept 2006 | - | $3000.00(>+9900.0%) |
| June 2006 | - | $0.00(-100.0%) |
| Mar 2006 | - | $9400.00(-99.9%) |
| Dec 2005 | $2.14 M(-87.3%) | - |
| Mar 2003 | - | $17.49 M(+3.5%) |
| Dec 2002 | $16.90 M(+51.7%) | $16.90 M(+4.4%) |
| Sept 2002 | - | $16.18 M(+5.1%) |
| June 2002 | - | $15.40 M(+15.7%) |
| Mar 2002 | - | $13.31 M(+19.4%) |
| Dec 2001 | $11.14 M(+90.0%) | $11.14 M(+27.3%) |
| Sept 2001 | - | $8.75 M(+38.3%) |
| June 2001 | - | $6.33 M(+14.5%) |
| Mar 2001 | - | $5.53 M(-5.8%) |
| Dec 2000 | $5.86 M(+34.0%) | $5.86 M(+40.9%) |
| Sept 2000 | - | $4.16 M(+0.5%) |
| June 2000 | - | $4.14 M(-0.2%) |
| Mar 2000 | - | $4.15 M(-5.2%) |
| Dec 1999 | $4.38 M(+102.4%) | $4.38 M(-8.8%) |
| Sept 1999 | - | $4.80 M(+37.1%) |
| June 1999 | - | $3.50 M(+25.0%) |
| Mar 1999 | - | $2.80 M(+29.5%) |
| Dec 1998 | $2.16 M(-25.4%) | $2.16 M(+44.2%) |
| Sept 1998 | - | $1.50 M(+25.0%) |
| June 1998 | - | $1.20 M(-69.2%) |
| Mar 1998 | - | $3.90 M(+34.5%) |
| Dec 1997 | $2.90 M(+163.6%) | $2.90 M(0.0%) |
| Sept 1997 | - | $2.90 M(+190.0%) |
| June 1997 | - | $1.00 M(-33.3%) |
| Mar 1997 | - | $1.50 M(+36.4%) |
| Dec 1996 | $1.10 M(+175.0%) | $1.10 M(+57.1%) |
| Sept 1996 | - | $700.00 K(-12.5%) |
| June 1996 | - | $800.00 K(+60.0%) |
| Mar 1996 | - | $500.00 K(+25.0%) |
| Dec 1995 | $400.00 K(-60.0%) | $400.00 K(+33.3%) |
| Sept 1995 | - | $300.00 K(-70.0%) |
| Dec 1994 | $1.00 M(+900.0%) | $1.00 M(+400.0%) |
| Mar 1994 | - | $200.00 K(+100.0%) |
| Dec 1993 | $100.00 K | $100.00 K(>+9900.0%) |
| Sept 1993 | - | $0.00(-100.0%) |
| June 1993 | - | $200.00 K(-77.8%) |
| Mar 1993 | - | $900.00 K |
FAQ
- What is Theriva Biologics annual total liabilities?
- What is the all time high annual total liabilities for Theriva Biologics?
- What is Theriva Biologics annual total liabilities year-on-year change?
- What is Theriva Biologics quarterly total liabilities?
- What is the all time high quarterly total liabilities for Theriva Biologics?
- What is Theriva Biologics quarterly total liabilities year-on-year change?
What is Theriva Biologics annual total liabilities?
The current annual total liabilities of TOVX is $15.52 M
What is the all time high annual total liabilities for Theriva Biologics?
Theriva Biologics all-time high annual total liabilities is $20.25 M
What is Theriva Biologics annual total liabilities year-on-year change?
Over the past year, TOVX annual total liabilities has changed by -$1.77 M (-10.26%)
What is Theriva Biologics quarterly total liabilities?
The current quarterly total liabilities of TOVX is $15.47 M
What is the all time high quarterly total liabilities for Theriva Biologics?
Theriva Biologics all-time high quarterly total liabilities is $29.94 M
What is Theriva Biologics quarterly total liabilities year-on-year change?
Over the past year, TOVX quarterly total liabilities has changed by -$2.19 M (-12.39%)